SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema

M. Fumagalli, F. Ferrari, E. Ansaldo, L. Fregonese, S. Viglio, I. Cerveri, M. Luisetti, J. Stolk, P. Iadarola (Pavia, Italy; Leiden, Netherlands)

Source: Annual Congress 2009 - COPD: basic science and clinical studies
Session: COPD: basic science and clinical studies
Session type: Thematic Poster Session
Number: 905
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fumagalli, F. Ferrari, E. Ansaldo, L. Fregonese, S. Viglio, I. Cerveri, M. Luisetti, J. Stolk, P. Iadarola (Pavia, Italy; Leiden, Netherlands). SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema. Eur Respir J 2009; 34: Suppl. 53, 905

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011

Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012


Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008



Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Analysis of exhaled breath condensate proteom and BAL Proteom by matrix assisted laser desorption/ioniosation – time of flight (MALDI-TOF) from patients with acute lung injury
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients
Source: International Congress 2017 – Management of COPD
Year: 2017

Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008



Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Is NMR-based metabolomic analysis of exhaled breath condensate accurate?
Source: Eur Respir J 2011; 37: 468
Year: 2011


Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study
Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017
Year: 2018



Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012

The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Exhaled breath condensate: metabolomics
Source: Eur Respir Monogr 2010; 49: 231-236
Year: 2010